期刊文献+
共找到62篇文章
< 1 2 4 >
每页显示 20 50 100
Therapeutic and Medicinal Uses of <i>Aloe vera</i>: A Review 被引量:5
1
作者 Pankaj K. Sahu Deen Dayal Giri +5 位作者 Ritu Singh Priyanka Pandey Sharmistha Gupta Atul Kumar Shrivastava Ajay Kumar Kapil Dev Pandey 《Pharmacology & Pharmacy》 2013年第8期599-610,共12页
The plant Aloe vera is used in Ayurvedic, Homoeopathic and Allopathic streams of medicine, and not only tribal community but also most of the people for food and medicine. The plant leaves contains numerous vitamins, ... The plant Aloe vera is used in Ayurvedic, Homoeopathic and Allopathic streams of medicine, and not only tribal community but also most of the people for food and medicine. The plant leaves contains numerous vitamins, minerals, enzymes, amino acids, natural sugars and other bioactive compounds with emollient, purgative, anti-microbial, anti inflammatory, antioxidant, aphrodisiac, anti-helmenthic, antifungal, antiseptic and cosmetic values for health care. This plant has potential to cure sunburns, burns and minor cuts, and even skin cancer. The external use in cosmetic primarily acts as skin healer and prevents injury of epithelial tissues, cures acne and gives a youthful glow to skin, also acts as extremely powerful laxative. 展开更多
关键词 ALOE vera Antimicrobial therapeutic MEDICINAL uses Cosmetic Application
下载PDF
Design,delivery and efficacy testing of therapeutic nucleic acids used to inhibit hepatitis C virus gene expression in vitro and in vivo 被引量:9
2
作者 Wolfgang H.Caselmann Matthias Serwe +3 位作者 Thomas Lehmann János Ludwig Brian S.Sproat Joachim W.Engels 《World Journal of Gastroenterology》 SCIE CAS CSCD 2000年第5期626-629,共4页
Despite major achievements in the treatment ofchronic hepatitis C with the combination ofinterferons and the nucleoside analog ribavirin themajority of patients with chronic hepatitis C virus(HCV) infection cannot be ... Despite major achievements in the treatment ofchronic hepatitis C with the combination ofinterferons and the nucleoside analog ribavirin themajority of patients with chronic hepatitis C virus(HCV) infection cannot be treated effectively.Toimprove this response rate we used antisensetechnologies to inhibit HCV translation as possibleadditional option for experimental treatment.Antisense oligodeoxynucleotides(ODN) are 展开更多
关键词 hepatitis C-like viruses/therapy gene expression in VITRO in vivo nucleic acids/therapeutic use CYTOMEGALOVIRUS
下载PDF
Continuous Wear of Hydrogel Contact Lenses for Therapeutic Use
3
作者 Daisuke Kudo Hiroshi Toshida +1 位作者 Toshihiko Ohta Akira Murakami 《Open Journal of Ophthalmology》 2012年第4期110-113,共4页
Purpose: To investigate the efficacy and complications of continuous wear of etafilcon A for therapeutic use. Materials and Methods: The subjects were 228 eyes of 219 outpatients prescribed contact lens (CL) for one w... Purpose: To investigate the efficacy and complications of continuous wear of etafilcon A for therapeutic use. Materials and Methods: The subjects were 228 eyes of 219 outpatients prescribed contact lens (CL) for one week of continuous therapeutic wear during 10 years. The reason for prescription of CLs, the primary disease, the duration of CL wear and the complications were assessed retrospectively. Results: The predominant reason for prescription of CLs was relief of pain or a foreign-body sensation (62.3%) and protection of the corneal epithelium (20.6%). The primary disease was post-penetrating keratoplasty (36.8%), followed by corneal epithelial erosion (14.5%), post-lamellar keratoplasty (14.0%) and bullous keratopathy (12.2%). The average duration of wearing single lens was 6.5 ± 3.2 days. The average duration of wearing CLs in total was 9.2 ± 10.7 months. The most frequent problem associated with continuous wear of CLs was their dropping out of CLs (12.3%). The complications associated with CLs included conjunctivitis with papillary hyperplasia, corneal erosion and superficial punctate keratitis, but corneal ulcer and corneal infiltrates were not found. Conclusion: Serious complications were not shown changing the lenses every week to keep to the prescribed time limit for continuous therapeutic wear, even if corneal epithelial barrier function is impaired. 展开更多
关键词 therapeutic use BANDAGE Soft Contact LENS CONTINUOUS WEAR COMPLICATION
下载PDF
Clinacanthus nutans:a review of the medicinal uses,pharmacology and phytochemistry 被引量:10
4
作者 Md.Ariful Alam Sahena Ferdosh +4 位作者 Kashif Ghafoor Md.Abdul Hakim Abdul Shukor Juraimi Alfi Khatib Md.Zaidul I.Sarker 《Asian Pacific Journal of Tropical Medicine》 SCIE CAS 2016年第4期393-399,共7页
Clinacanthus nutans Lindau is known as snake grass belonging to the Acanlhaceae family.This plant has diverse and potential medicinal uses in traditional herbal medicine for treating skin rashes,insects and snake bite... Clinacanthus nutans Lindau is known as snake grass belonging to the Acanlhaceae family.This plant has diverse and potential medicinal uses in traditional herbal medicine for treating skin rashes,insects and snake bites,lesions caused by herpes simplex virus,diabetes,and gout in Malaysia.Indonesia.Thailand and China.Phylochemieal investigations documented the varied contents of bioaclive compounds from litis plant namely flavonoids,glycosides,glycoglyeerolipids.cerebrosides and monoacylmonogalatosylglycerol.The pharmacological experiment proved that various types of extracts and pure compounds from this species exhibited a broad range of biological properties such as anti-inflammatory,antiviral,antioxidant,and anti-diabetic activities.The lindings of toxicity study showed that extracts from this plant did not show any toxicity thus it can be used as strong therapeutic agents for specific diseased conditions.However,further experiments on chemical components and their mode of action showing biological activities are required to elucidate the complete phytochemical profile and assess to confirm their suitability tor future drugs.This review summarizes the medicinal uses,phytochemistry and pharmacology of this plant in order to explore its therapeutic potential and gaps necessitating for prospected research work. 展开更多
关键词 Clinacanthus nutans MEDICINAL uses PHYTOCHEMICALS PHARMACOLOGY therapeutic potential
下载PDF
Comparison of long-lasting therapeutic effects between succimer and penicillamine on hepatolenticular degeneration 被引量:3
5
作者 REN Ming Shan, ZHANG Zhi, WU Jun Xia, LI Fei, XUE Ben Chun and YANG Ren Min 《World Journal of Gastroenterology》 SCIE CAS CSCD 1998年第6期75-77,共3页
AIM To compare the long term effect of succimer (Suc) with that of penicillamine (Pen) in treating hepatolenticular degeneration (HLD). METHODS One hundred and twenty patients with HLD were divided into 2 groups. ... AIM To compare the long term effect of succimer (Suc) with that of penicillamine (Pen) in treating hepatolenticular degeneration (HLD). METHODS One hundred and twenty patients with HLD were divided into 2 groups. Group A ( n =60) received Suc 750mg , po. bid. Group B ( n =60) received Pen 250mg , po. qid. The period of maintenance treatment varied from 6 months to 3 years, averaging 1 5 years. Symptoms and therapeutic effects were evaluated by modified Goldstein scale. RESULTS The total effectiveness of group A in two different periods of treatment were 80% and 85% respectively, higher than those of group B (58% and 59% respectively) ( P <0 05). Suc also had obvious curative effects for the patients who failed in the use of Pen. There were fewer side effect in group A than in group B ( P <0 05). Suc and Pen could increase urinary copper excretion effectively and continually. CONCLUSION Suc is more effective and safer than Pen. Clinically, it can replace Pen as first choice drug for long term maintenance therapy of HLD. 展开更多
关键词 hepatolenticular degeneration/drug THERAPY succimer/therapeutic use penicillamine/therapeutic use
下载PDF
Functional dyspepsia of ulcer-dysmotility type:clinical incidence and therapeutic strategy 被引量:3
6
作者 WANG XiaoZhong and LIN GuZhen 《World Journal of Gastroenterology》 SCIE CAS CSCD 1998年第4期95-96,共2页
Functionaldyspepsiaofulcerdysmotilitytype:clinicalincidenceandtherapeuticstrategyWANGXiaoZhongandLINGuZhe... Functionaldyspepsiaofulcerdysmotilitytype:clinicalincidenceandtherapeuticstrategyWANGXiaoZhongandLINGuZhenSubjectheaadings... 展开更多
关键词 dyspepsia/drug therapy famotidine/therapeutic use cisapride/therapeutic use peptic ULCER gastrointestinal motility
下载PDF
Therapeutic role of template-based lymphadenectomy in urothelial carcinoma of the upper urinary tract 被引量:5
7
作者 Tsunenori Kondo Toshio Takagi Kazunari Tanabe 《World Journal of Clinical Oncology》 CAS 2015年第6期237-251,共15页
Lymphadenectomy for urothelial carcinoma of the upper urinary tract has attracted the attention of physicians. The mapping study of lymphatic spread has shown that a relatively wide area should comprise the regional n... Lymphadenectomy for urothelial carcinoma of the upper urinary tract has attracted the attention of physicians. The mapping study of lymphatic spread has shown that a relatively wide area should comprise the regional nodes for tumors of the right renal pelvis or the right upper two-thirds of the ureter. A prospective study showed that an anatomical templatebased lymphadenectomy significantly improved patient survival in tumors of the renal pelvis. This benefit was more evident for patients with p T2 stage tumors or higher. The risk of regional node recurrence is significant reduced by template-based lymphadenectomy,which is likely to be associated with improved patient survival. The removal of lymph node micrometastases is assumed to be the reason for therapeutic benefit following lymphadenectomy. The number of resected lymph nodes can be used to assess the quality of lymphadenectomy,but not to determine the extent of lymphadenectomy. The guidelines currently recommend lymphadenectomy for patients with muscle-invasive disease,even though the current recommendation grades are still low. The present limitation of lymphadenectomy is the lack of standardization of the extent of lymphadenectomy and the randomized trials. Further studies are warranted to collect the evidence to support lymphadenectomy. 展开更多
关键词 LYMPHADENECTOMY LYMPH node EXCISION UROTHELIAL carcinoma Treatment outcome therapeutic uses Diagnosis GUIDELINE
下载PDF
Blastocystis hominis as a cause of chronic diarrhea in low-resource settings:A systematic review
8
作者 Stephen Amoak Jonathan Soldera 《World Journal of Meta-Analysis》 2024年第3期30-41,共12页
BACKGROUND Blastocystis hominis(B.hominis),an anaerobic unicellular protist parasite,is known for its diverse clinical manifestations upon infecting the human gastrointestinal tract.Although globally distributed,it is... BACKGROUND Blastocystis hominis(B.hominis),an anaerobic unicellular protist parasite,is known for its diverse clinical manifestations upon infecting the human gastrointestinal tract.Although globally distributed,it is particularly prevalent in developing nations.Examining the symptoms and treatment outcomes of B.hominis infection in low-resource settings holds immense significance,providing healthcare practi-tioners with valuable insights to enhance patient care.AIM To synthesize existing evidence on the symptomatology and treatment outcomes of B.hominis infection in low-resource settings.METHODS Following the Preferred Reporting Items for Systematic Review and Meta-Analysis guidelines,a systematic review was conducted.The search spanned electronic databases including PubMed,Scopus,and Google Scholar.After a comprehensive screening process,a thorough examination of the papers,adhering to inclusion and exclusion criteria,and data extraction from eligible studies was conducted.The findings underwent summarization through simple descriptive analysis.RESULTS The search yielded 1200 papers,with 17 meeting inclusion criteria.Chronic diarrhea due to B.hominis infection was reported in only two studies,while abdominal pain,diarrhea,flatulence,constipation,and nausea/vomiting emerged as the most commonly documented symptoms.Recovery rates after one week of treatment ranged from 71.8%to 100%,and after two weeks,from 60%to 100%.CONCLUSION In low-resource settings,chronic diarrhea resulting from B.hominis infection is infrequent.Common symptoms include abdominal pain,diarrhea,flatulence,constipation,and nausea/vomiting.Post-treatment,clinical outcomes are notably favorable,supporting the recommendation for treatment.Metronidazole is advocated as the first-line agent,with consideration for switching to a second-line option in cases of treatment failure or poor response. 展开更多
关键词 Blastocystis infections Gastrointestinal diseases Treatment outcome Developing countries Metronidazole/therapeutic use
下载PDF
High-intensity focused ultrasound extracorporeal ablation of liver tissuesin rabbits
9
《World Journal of Gastroenterology》 SCIE CAS CSCD 1998年第2期16-16,共1页
HighintensityfocusedultrasoundextracorporealablationoflivertissuesinrabbitsCHENGShuQun1,ZHOUXinDa1,TANGZ... HighintensityfocusedultrasoundextracorporealablationoflivertissuesinrabbitsCHENGShuQun1,ZHOUXinDa1,TANGZhaoYou1,YUYao1,B... 展开更多
关键词 LIVER neoplasms experimental/therapy ultrasonic THERAPY iodized oil/therapeutic use liver/radiation effects randomized controlled trials
下载PDF
Controversies regarding transplantation of mesenchymal stem cells
10
作者 Tsvetelina Velikova Tereza Dekova Dimitrina Georgieva Miteva 《World Journal of Transplantation》 2024年第2期48-61,共14页
Mesenchymal stem cells(MSCs)have tantalized regenerative medicine with their therapeutic potential,yet a cloud of controversies looms over their clinical tran-splantation.This comprehensive review navigates the intric... Mesenchymal stem cells(MSCs)have tantalized regenerative medicine with their therapeutic potential,yet a cloud of controversies looms over their clinical tran-splantation.This comprehensive review navigates the intricate landscape of MSC controversies,drawing upon 15 years of clinical experience and research.We delve into the fundamental properties of MSCs,exploring their unique immuno-modulatory capabilities and surface markers.The heart of our inquiry lies in the controversial applications of MSC transplantation,including the perennial debate between autologous and allogeneic sources,concerns about efficacy,and lingering safety apprehensions.Moreover,we unravel the enigmatic mechanisms surro-unding MSC transplantation,such as homing,integration,and the delicate balance between differentiation and paracrine effects.We also assess the current status of clinical trials and the ever-evolving regulatory landscape.As we peer into the future,we examine emerging trends,envisioning personalized medicine and innovative delivery methods.Our review provides a balanced and informed perspective on the controversies,offering readers a clear understanding of the complexities,challenges,and potential solutions in MSC transplantation. 展开更多
关键词 Mesenchymal stem cells Transplantation controversies Regenerative medicine Autoimmune diseases Chronic inflammatory illnesses Tumor growth METASTASIS therapeutic potential Clinical use of mesenchymal stem cell
下载PDF
USE OF CELL-BASED BIOASSAY FOR THE QUALITY CONTROL OF BOTANICAL THERAPEUTICS
11
作者 Doo Suk Lee Min-Jung Bae Sunyoung Kim 《World Journal of Traditional Chinese Medicine》 2015年第4期91-91,共1页
The single most important factor in modernization efforts of traditional oriental medicines is the limited understanding of active compounds responsible for claimed therapeutic effects.Indeed,the unknown identity of b... The single most important factor in modernization efforts of traditional oriental medicines is the limited understanding of active compounds responsible for claimed therapeutic effects.Indeed,the unknown identity of biologically active molecules generates major difficulties associated with botanical therapeutics in general.This includes management of raw materials,poor understanding of 展开更多
关键词 use OF CELL-BASED BIOASSAY FOR THE QUALITY CONTROL OF BOTANICAL therapeuticS PG
原文传递
尼莫地平透皮制剂的研究 被引量:15
12
作者 周建平 钟鸣 黄建华 《中国药科大学学报》 CAS CSCD 北大核心 2000年第5期348-351,共4页
采用改良Franz扩散装置和家兔离体皮肤 ,进行了尼莫地平透皮制剂的研究。结果表明 :在同一促渗剂条件下 ,软膏剂载药量 2 0 40mg/g透皮量最大 ,涂膜剂和贴剂载药量则在 40mg/g和 4.0mg/cm2 为优 ;制剂 2 4h累积透皮量大小次序为 :涂膜剂... 采用改良Franz扩散装置和家兔离体皮肤 ,进行了尼莫地平透皮制剂的研究。结果表明 :在同一促渗剂条件下 ,软膏剂载药量 2 0 40mg/g透皮量最大 ,涂膜剂和贴剂载药量则在 40mg/g和 4.0mg/cm2 为优 ;制剂 2 4h累积透皮量大小次序为 :涂膜剂 >软膏剂 >贴剂 ,时滞为 :贴剂 >涂膜剂≈软膏剂 ;PVP作为涂膜剂载体材料能增加尼莫地平的透皮量 ,在贴剂复合膜材料中 ,当EC∶PVP =3∶2时 ,具有较好的成膜性和透皮性 ;在贴剂处方中 ,5 .6 %Azone具有较大的透皮促渗作用。 展开更多
关键词 尼莫地平 透皮制剂 促渗剂 透皮性
下载PDF
银杏叶提取物联合尼莫地平对轻中度血管性痴呆患者血清同型半胱氨酸、S100B及认知功能的影响 被引量:19
13
作者 曹冰清 王涛 +1 位作者 康涛 谢瑱 《陕西医学杂志》 CAS 2018年第3期379-381,385,共4页
目的:观察银杏叶注射剂液联合尼莫地平治疗轻中度血管性痴呆的临床疗效及血同型半胱氨酸(Hcy)和S100B蛋白的影响。方法:将98例轻中度血管性痴呆患者随机平均分为两组,对照组给予尼莫地平治疗,试验组给予银杏叶提取物联合尼莫地平治疗,... 目的:观察银杏叶注射剂液联合尼莫地平治疗轻中度血管性痴呆的临床疗效及血同型半胱氨酸(Hcy)和S100B蛋白的影响。方法:将98例轻中度血管性痴呆患者随机平均分为两组,对照组给予尼莫地平治疗,试验组给予银杏叶提取物联合尼莫地平治疗,其中尼莫地平的治疗方案同对照组。4周后采用简易智能状态检查量表(MMSE)、日常生活能力量表(ADL)及测定患者血Hcy和S100B蛋白的含量。结果:治疗4周后,试验组总有效率高于对照组,差异有统计学意义(P<0.05),试验组在MMSE、ADL评分方面较对照组均有显著改善,其差异有统计学意义(P<0.05)。治疗后两组的Hcy和S100B蛋白均明显降低,治疗组降低更明显,与对照组比较差异具有统计学意义(P<0.05)。结论:银杏叶注射液联合尼莫地平治疗血管性痴呆的临床疗效较好,可有效改善患者认知功能,并降低血Hcy和S100B的水平。 展开更多
关键词 痴呆 血管性/药物疗法 银杏叶 尼莫地平/治疗应用 乙酰半胱氨酸/分析 @S100B蛋白
下载PDF
阿司匹林与尼莫地平在偏头痛治疗中的效果比较 被引量:5
14
作者 盛飞 李庭毅 李文辉 《中国当代医药》 2019年第16期62-64,共3页
目的对阿司匹林与尼莫地平治疗偏头痛中的效果进行观察及分析。方法选取2016年8月~2018年8月在我院接受治疗的100例偏头痛患者作为研究对象,按照治疗方案的不同分成研究组和参照组,每组各50例。参照组实施尼莫地平治疗,研究组实施阿司... 目的对阿司匹林与尼莫地平治疗偏头痛中的效果进行观察及分析。方法选取2016年8月~2018年8月在我院接受治疗的100例偏头痛患者作为研究对象,按照治疗方案的不同分成研究组和参照组,每组各50例。参照组实施尼莫地平治疗,研究组实施阿司匹林治疗方案,比较两组的治疗效果,包括观察治疗总有效率、并发症发生率、复发率等指标。结果研究组的治疗总有效率(96.00%)高于参照组(80.00%),差异有统计学意义(P<0.05);研究组的并发症总发生率(4.00%)明显的低于参照组(18.00%),差异有统计学意义(P<0.05);研究组的复发率(2.00%)显著低于参照组(18.00%),差异有统计学意义(P<0.05)。结论在治疗偏头痛时,应用尼莫地平和阿司匹林均可获得一定的成效,但相较于尼莫地平而言,阿司匹林的治疗效果更显著。 展开更多
关键词 阿司匹林 尼莫地平 偏头痛 治疗效果 比较观察
下载PDF
法舒地尔与尼莫地平不同给药途径预防动脉瘤栓塞术后脑血管痉挛的疗效比较 被引量:5
15
作者 卢军栋 齐凡星 +5 位作者 苏鹏 刘洁 常文龙 李恳 康丽娟 郭艳敏 《医学临床研究》 CAS 2015年第4期725-727,共3页
【目的】探讨法舒地尔与尼莫地平不同给药途径对脑动脉瘤栓塞术后发生脑血管痉挛的防治价值。【方法】收集自2010年1月至2014年1月本院脑动脉瘤栓塞术后患者74例,随机分为两组,每组37例。对照组患者术中使用尼莫地平静脉滴注扩脑血管... 【目的】探讨法舒地尔与尼莫地平不同给药途径对脑动脉瘤栓塞术后发生脑血管痉挛的防治价值。【方法】收集自2010年1月至2014年1月本院脑动脉瘤栓塞术后患者74例,随机分为两组,每组37例。对照组患者术中使用尼莫地平静脉滴注扩脑血管,观察组患者经动脉微导管推注法舒地尔进行扩血管治疗。比较两组患者脑脊液S100蛋白和血清神经元特异性烯醇化酶(NSE)变化,采用格拉斯哥预后评分评价治疗效果,比较两组患者的不良反应发生情况。【结果】两组患者治疗后脑脊液S100蛋白以及血清NSE均显著高于治疗前( P <0.05),治疗后尼莫地平组脑脊液S100蛋白以及血清NSE均显著高于法舒地尔组,且两组相比较差异有显著性( P <0.05)。两组均无死亡病例,法舒地尔组总有效率(91.9%)显著高于尼莫地平组(75.7%)( P <0.05)。法舒地尔组不良反应发生率显著低于尼莫地平组(18.9% vs 43.2%,P<0.05)。【结论】法舒地尔与尼莫地平都具有缓解脑血管痉挛的效果,能有效减少脑血管痉挛的发生,减少脑损伤,且法舒地尔预防和治疗脑血管痉挛的效果优于尼莫地平。 展开更多
关键词 尼莫地平/治疗应用 颅内动脉瘤/外科学 栓塞 治疗性/副作用 血管痉挛 颅内/预防和控制
下载PDF
心脉通片治疗高血压病的疗效观察 被引量:6
16
作者 梁碧伟 《中药材》 CAS CSCD 北大核心 2005年第7期634-636,共3页
目的:观察心脉通片治疗高血压的临床疗效。方法:对入选的200例原发性高血压患者随机分为治疗组(心脉通组)和对照组(尼莫地平组),治疗6周后比较两组之间的疗效。结果:治疗组治疗高血压的降压幅度较对照组明显,两组间比较有显著性差异(P&l... 目的:观察心脉通片治疗高血压的临床疗效。方法:对入选的200例原发性高血压患者随机分为治疗组(心脉通组)和对照组(尼莫地平组),治疗6周后比较两组之间的疗效。结果:治疗组治疗高血压的降压幅度较对照组明显,两组间比较有显著性差异(P<0.05)。结论:治疗组治疗高血压临床疗效优于对照组,且无明显副作用。 展开更多
关键词 心脉通片 疗效观察 高血压病 原发性高血压患者 临床疗效 显著性差异 对照组 治疗组 尼莫地平 降压幅度 副作用
下载PDF
尼莫地平对急性一氧化碳中毒小鼠脑损伤的治疗作用 被引量:1
17
作者 赵晓辉 杨俊卿 周岐新 《工业卫生与职业病》 CAS CSCD 北大核心 2002年第3期163-166,共4页
目的 研究尼莫地平对急性一氧化碳 (CO)中毒致小鼠脑损伤的治疗作用。方法 小鼠单次腹腔注射CO 170ml/kg,以CO中毒小鼠死亡率、被动回避性记忆能力、脑细胞膜和线粒体膜Ca2 + Mg2 +ATP酶 (Ca2 + Mg2 + ATPase)活性和脑组织单胺氧化... 目的 研究尼莫地平对急性一氧化碳 (CO)中毒致小鼠脑损伤的治疗作用。方法 小鼠单次腹腔注射CO 170ml/kg,以CO中毒小鼠死亡率、被动回避性记忆能力、脑细胞膜和线粒体膜Ca2 + Mg2 +ATP酶 (Ca2 + Mg2 + ATPase)活性和脑组织单胺氧化酶 -B (MAO B)活性的改变以及海马神经元细胞病理改变为指标 ,研究尼莫地平对急性CO中毒致小鼠脑损伤的治疗作用。结果 尼莫地平以剂量依赖性的方式降低CO中毒小鼠的死亡率 ,明显改善CO中毒小鼠下降的记忆能力 ,显著阻遏CO中毒小鼠脑细胞膜和线粒体膜Ca2 + Mg2 + ATPase活性的病理性降低以及脑组织MAO B活性的病理性升高 ,明显减轻海马神经元的迟发性坏死 ;此治疗作用以尼莫地平 15min内给予较为明显。结论 在急性CO中毒早期给予足量尼莫地平对急性CO中毒所致脑损伤有显著的治疗作用。 展开更多
关键词 尼莫地平 急性一氧化碳中毒 小鼠 脑损伤 治疗作用
下载PDF
丁苯酞联合尼莫地平治疗血管性认知功能障碍疗效观察 被引量:9
18
作者 曾湘良 朱勇 +1 位作者 刘芳 柴红波 《现代医药卫生》 2013年第1期43-44,共2页
目的观察丁苯酞(NBP)软胶囊联合尼莫地平治疗血管性认知功能障碍的临床疗效。方法将180例血管性认知功能障碍患者随机分为三组,NBP组、尼莫地平组、联合组,分别接受NBP软胶囊治疗、尼莫地平治疗、NBP软胶囊和尼莫地平联合治疗。1个月为... 目的观察丁苯酞(NBP)软胶囊联合尼莫地平治疗血管性认知功能障碍的临床疗效。方法将180例血管性认知功能障碍患者随机分为三组,NBP组、尼莫地平组、联合组,分别接受NBP软胶囊治疗、尼莫地平治疗、NBP软胶囊和尼莫地平联合治疗。1个月为1个疗程,治疗前后均运用简易智力状态检查量表(MMSE)积分法对临床疗效进行评价。结果 4周后NBP组总有效率为80%,联合组总有效率为90%,均明显高于尼莫地平组,各组治疗前、后MMSE积分比较,差异有统计学意义(P<0.05),而联合组总有效率最高,MMSE积分的变化最明显,同时不良反应无明显增加。结论 NBP软胶囊是治疗血管性认知功能障碍的有效药物之一,尼莫地平对血管性认知功能障碍也有一定的效果,二者联合使用能显著改善血管性认知功能障碍患者的MMSE评分,临床疗效确切、安全。 展开更多
关键词 痴呆 血管性 药物疗法 卒中 并发症 认知障碍 药物疗法 认知障碍 病因学 尼莫地平 治疗应用 丁苯酞软胶囊 治疗应用 简易智力状态检查量表
下载PDF
尼莫地平对脑缺血时间窗的影响 被引量:4
19
作者 李淑婷 吉训明 罗玉敏 《罕少疾病杂志》 2009年第2期15-18,共4页
目的研究尼莫地平对大鼠脑缺血/再灌注损伤治疗时间窗的影响。方法将60只成年雄性Wistar大鼠随机分成,尼莫地平组和对照组两大组。每个大组再分成5个小组,即MCAO2h,3h,4h,5h和6h组。应用线栓法制作大鼠MCAO模型。于再灌注前20min、再灌... 目的研究尼莫地平对大鼠脑缺血/再灌注损伤治疗时间窗的影响。方法将60只成年雄性Wistar大鼠随机分成,尼莫地平组和对照组两大组。每个大组再分成5个小组,即MCAO2h,3h,4h,5h和6h组。应用线栓法制作大鼠MCAO模型。于再灌注前20min、再灌注后12h和36h尾静脉给药;48h后计算大鼠存活率、行神经功能缺损评分、脑血流量和脑梗死体积测定。结果①大鼠存活率:尼莫地平组存活率为53.3%(16/30只),对照组为40%(12/30只)。大鼠存活率提高,但没有统计学意义。②神经功能缺损评分:尼莫地平组神经功能缺损明显少于对照组。其中MCAO4h的大鼠神经功能尼莫地平组明显好于对照组(P<0.05)。③脑组织血流量:尼莫地平组的大鼠脑血流量明显大于对照组(P<0.05)。各时段大鼠脑血流量,尼莫地平组也明显大于对照组,其中MCAO2h,3h和4h有统计学意义(P<0.05)。④梗死体积:尼莫地平组的大鼠脑梗死体积明显小于对照组,其中MCAO2h组的大鼠脑梗死体积减小最突出(P<0.05)。结论尼莫地平对大鼠脑缺血/再灌注损伤模型的治疗时间窗的影响在2h~4h范围。 展开更多
关键词 脑缺血时间窗 尼莫地平 MCAO神经保护
下载PDF
尼莫地平干预治疗中老年原发性失眠的疗效观察 被引量:3
20
作者 潘博希 王明红 +2 位作者 冯蕾 陈维 林亚明 《现代医药卫生》 2012年第15期2275-2276,共2页
目的探讨尼莫地平干预治疗中老年原发性失眠的作用。方法选择60例中老年原发性失眠患者,随机分为干预组和对照组。对照组给予常规按需服用艾司唑仑片,干预组在常规按需服用镇静催眠药基础上,加用尼莫地平干预治疗。比较两组治疗前与治疗... 目的探讨尼莫地平干预治疗中老年原发性失眠的作用。方法选择60例中老年原发性失眠患者,随机分为干预组和对照组。对照组给予常规按需服用艾司唑仑片,干预组在常规按需服用镇静催眠药基础上,加用尼莫地平干预治疗。比较两组治疗前与治疗后1个月匹茨堡睡眠质量指数量表(PSQI)评分情况及艾司唑仑用量。结果给予尼莫地平干预治疗后,患者PSQI评分及艾司唑仑用量下降差值均比对照组明显,差异有统计学意义(P<0.05)。结论尼莫地平干预治疗有助于改善中老年原发性失眠患者的临床症状,减少苯二氮类药物的用量。 展开更多
关键词 入睡和睡眠障碍/药物疗法 尼莫地平/治疗应用 中年人 老年人
下载PDF
上一页 1 2 4 下一页 到第
使用帮助 返回顶部